You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC / CE

Expert Perspectives on AL Amyloidosis: Timely Identification for Improved Outcomes

  • Authors: Ray Comenzo, MD; Angela Dispenzieri, MD; Ronald Witteles, MD
  • CME / ABIM MOC / CE Released: 4/29/2021
  • THIS ACTIVITY HAS EXPIRED FOR CREDIT
  • Valid for credit through: 4/29/2022
Start Activity


Target Audience and Goal Statement

This activity is intended for cardiologists, nephrologists, hematologists, primary care physicians, and nurses.

The goal of this activity is to educate clinicians about amyloid light chain (AL) amyloidosis characteristics and the importance of coordinating timely care with the interprofessional team.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • The clinical presentation of AL amyloidosis
    • Data for emerging and new therapies for the treatment of AL amyloidosis
  • Have greater competence related to
    • The diagnostic evaluation of patients who present with symptoms consistent with AL amyloidosis


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Faculty

  • Ray Comenzo, MD

    Director, John C. Davis Myeloma & Amyloid Program
    Professor, Tufts University School of Medicine in Boston, Massachusetts

    Disclosures

    Disclosure: Ray Comenzo, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: AbbVie/Genentech; Caelum/Alexion; Janssen; Karyopharm; Sanofi; Takeda
    Received grants for clinical research from: Caelum/Alexion; Janssen
    Other: Anti-CD38 Antibodies for Treatment of Light Chain Amyloidosis and Other CD38-Positive Hematological Malignancies. Patent WO2016187546A1

  • Angela Dispenzieri, MD

    Serene and Frances C. Durling Professor of Medicine and of Laboratory Medicine, and Pathology
    Hematology Research Chair
    Mayo Clinic
    Rochester, Minnesota

    Disclosures

    Disclosure: Angela Dispenzieri, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Alnylam; Intellia; Janssen
    Received grants for clinical research from: Alnylan; Celgene; Janssen; Pfizer; Prothena; Takeda

  • Ronald Witteles, MD

    Professor of Cardiovascular Medicine
    Co-Director, Stanford Amyloid Center
    Stanford University School of Medicine
    Palo Alto, California

    Disclosures

    Disclosure: Ronald Witteles, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Alnylam; Eidos; Ionis/Akcaea; Pfizer
    Received grants for clinical research from: Alnylam; Eidos; Ionis/Akcaea; Pfizer

Editor

  • Cheryl Perkins, MD, RPh

    Medical Education Director, Medscape, LLC

    Disclosures

    Disclosure: Cheryl L Perkins, MD, RPh, has disclosed no relevant financial relationships.

CME, CE Reviewer / Nurse planneri

  • Hazel Dennison, DNP, RN, FNP-BC, CHCP, CPHQ, CNE

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Hazel Dennison, DNP, RN, FNP, CHCP, CPHQ, CNE, has disclosed no relevant financial relationships.

Medscape, LLC staff have disclosed that they have no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

    Contact This Provider

    For Nurses

  • Awarded 0.50 contact hour(s) of continuing nursing education for RNs and APNs; 0.25 contact hours are in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

Expert Perspectives on AL Amyloidosis: Timely Identification for Improved Outcomes

Authors: Ray Comenzo, MD; Angela Dispenzieri, MD; Ronald Witteles, MDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME / ABIM MOC / CE Released: 4/29/2021

Valid for credit through: 4/29/2022

processing....

 

 

  • Print